Disease/Infection News

RSS

Blood cell damage in COVID-19 may compromise oxygen transport

Researchers in the U.S. have shown that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may alter key protein structures on red blood cells and compromise the transport and delivery of oxygen in patients with coronavirus disease 2019 (COVID-19).

1 Jul 2020

CHOP researchers receive multi-million dollar grant to study disease risk in African Americans

The National Institutes of Health announced today that researchers from Children's Hospital of Philadelphia are among the recipients of a multi-million dollar grant that focuses on the use of genomics to improve risk assessment for diverse populations and integrate the findings into clinical care.

1 Jul 2020

UMass Amherst biostatistician awarded federal grants to support research on pandemic forecasting

University of Massachusetts Amherst biostatistician Nicholas Reich has been awarded grants from the U.S. Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) to support innovation and expansion in his groundbreaking pandemic forecasting work.

1 Jul 2020

Clinical-grade wearables provide continuous on-body sensing for COVID-19

Although it might be tempting to rely on your fitness tracker to catch early signs of COVID-19, Northwestern University researchers caution that consumer wearables are not sophisticated enough to monitor the complicated illness.

1 Jul 2020

Among those disrupted by COVID-19: The nation’s newest doctors

July 1 is a big day in medical education. It's traditionally the day newly minted doctors start their first year of residency. But this year is different. Getting from here to there — from medical school to residency training sites — has been complicated by the coronavirus.

1 Jul 2020

Telehealth plays an important role in preventing the spread of COVID-19

Rural hospitals are more likely than urban facilities to have access to telehealth, a once-underused service that now is playing a key role in treating coronavirus patients, according to research by two health administration professors in Florida Atlantic University's College of Business.

1 Jul 2020

Repeated sampling of FIB-4 score can increase the prediction of future liver cirrhosis

Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a new study from Karolinska Institutet in Sweden published in the Journal of Hepatology.

1 Jul 2020

Air pollution may lead to interstitial lung diseases

More research must be done to investigate the role of air pollution on the epigenome in patients with interstitial lung diseases (ILDs), in order to develop strategies that minimize the effects of these pollutants, according to a new article published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

1 Jul 2020

COVID-19 tests provide much-needed information to help manage the infection

Testing for COVID-19 can give us some much-needed information to help understand and manage this viral infection on an individual, local, national and global level.

1 Jul 2020

Phosphorylation of SARS-CoV-2 N protein affects its function

Now, a new study by researchers at the University of California San Francisco and published on the preprint server bioRxiv* in June 2020 shows the effect of phosphorylation on the state and function of the N protein.

1 Jul 2020

Researchers identify optimal face masks for controlling respiratory droplets

While the use of face masks in public has been widely recommended by public health officials during the current COVID-19 pandemic, there are relatively few specific guidelines pertaining to mask materials and designs.

1 Jul 2020

Study identifies the cause of blood clotting in Covid-19 patients

One of the major mysteries in treating patients with Covid-19 is the frequent development of blood clots that can subsequently damage their organs and sometimes be fatal.

1 Jul 2020

Kansans depend on local authorities for reliable COVID-19 information, shows survey

New information emerges about the novel coronavirus on a daily basis, sometimes confirming, other times contradicting what we thought we knew the day before.

1 Jul 2020

Study reveals a new target for tuberculosis drug development

Biology students and faculty members from The University of Texas at El Paso have discovered a new target for tuberculosis drug development.

1 Jul 2020

BMI should be assessed in management of COVID-19 patients

A new study published on the preprint server medRxiv* in June 2020 reports that obesity is a risk factor of composite poor outcome of COVID-19 disease. On the other hand, COVID-19 patients with 'composite poor outcome' have higher BMI. Therefore, BMI should be assessed in the management of COVID-19 patients, and special attention should be given to patients with obesity.

1 Jul 2020

SARS-CoV-2 circulating in Brazil back in November 2019

The finding, published on the preprint server medRxiv in June 2020, shows that it has been causing infection in Brazil long before the first case was reported in the Americas, North and South, in January 2020, and certainly before the first case in this Brazilian region.

1 Jul 2020

Silk useful as face mask and PPE in COVID-19

As many people are resorting to face coverings improvised from common fabrics, researchers from the University of Cincinnati looked to determine what fabrics were the most effective. The team examined the hydrophobicity of fabrics (silk, cotton, polyester), as measured by their resistance to the penetration of small and aerosolized water droplets, an important transmission avenue for the virus causing COVID-19.

30 Jun 2020

Oral hygiene and severity of COVID-19 – the connection

Their study titled, “Could there be a link between oral hygiene and the severity of SARS-CoV-2 infections?” was published in the latest issue of the journal British Dental Journal.

30 Jun 2020

Herd immunity in the U.S. unlikely

The race to develop an effective vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is on, with many vaccine candidates entering the human trial phase. When a vaccine is developed and introduced into the population at scale, it triggers herd immunity, with many people immune to the infectious disease.

30 Jun 2020